Peel Hunt Keeps GBX 5130.00 Target Price On Berkeley Group Holdings The PLC (LON:BKG), Keeps “Add” Rating; Endurant Capital Management LP Upped By $5.47 Million Its Abbvie (ABBV) Stake

The Berkeley Group Holdings plc (LON:BKG) Logo

Endurant Capital Management Lp increased Abbvie Inc (ABBV) stake by 82.01% reported in 2019Q3 SEC filing. Endurant Capital Management Lp acquired 72,999 shares as Abbvie Inc (ABBV)’s stock rose 30.40%. The Endurant Capital Management Lp holds 162,007 shares with $12.27M value, up from 89,008 last quarter. Abbvie Inc now has $132.00B valuation. The stock increased 1.20% or $1.06 during the last trading session, reaching $89.26. About 8.18 million shares traded or 10.31% up from the average. AbbVie Inc. (NYSE:ABBV) has declined 3.71% since January 16, 2019 and is downtrending. It has underperformed by 3.71% the S&P500. Some Historical ABBV News: 26/04/2018 – ABBVIE SEES YR ADJ. EPS $7.66-$7.76, SAW $7.33-$7.43, EST.$7.54; 24/04/2018 – MERCK PHASE 1 KEYTRUDA STUDY SUSPENDED: CLINICALTRIALS.GOV; 05/04/2018 – BIOGEN INC – PRECISE TERMS OF AGREEMENT WITH ABBVIE ARE CONFIDENTIAL; 20/03/2018 – EXACT SCIENCES CORP – STENHOUSE, VICE PRESIDENT, U.S. IMMUNOLOGY AT ABBVIE, WILL ASSUME NEW POSITION ON APRIL 2, 2018; 22/03/2018 – AbbVie in $25bn wipeout after cancer drug results; 30/05/2018 – AbbVie Announces Preliminary Results of Tender Offer; 31/05/2018 – Phase l/Il Study Design of Birinapant in Combination With Keytruda® to be Presented on June 4 at the ASCO Annual Meeting; 26/04/2018 – AbbVie 1Q EPS $1.74; 08/05/2018 – ENANTA PHARMACEUTICALS INC – ROYALTY REVENUE FOR QUARTER INCREASED TO $44.0 MLN DUE TO INCREASE IN ABBVIE’S MAVYRET SALES; 26/04/2018 – AbbVie 1Q Net $2.78B

Peel Hunt have a GBX 5130.00 target price per share on the stock. The target price per share suggests a potential upside of 4.97% from Berkeley Group Holdings The PLC (LON:BKG)‘s last stock close. This rating was disclosed to clients in an analyst report on Monday morning.

Among 5 analysts covering AbbVie (NYSE:ABBV), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. AbbVie has $9800 highest and $7900 lowest target. $91.40’s average target is 2.40% above currents $89.26 stock price. AbbVie had 11 analyst reports since August 20, 2019 according to SRatingsIntel. Citigroup maintained the shares of ABBV in report on Wednesday, November 20 with “Buy” rating. The company was maintained on Thursday, December 26 by Cowen & Co. The company was upgraded on Tuesday, August 20 by Piper Jaffray. The company was maintained on Monday, November 4 by Wolfe Research. The firm has “Buy” rating by UBS given on Thursday, September 12. The rating was maintained by Piper Jaffray with “Overweight” on Wednesday, September 4. The stock of AbbVie Inc. (NYSE:ABBV) earned “Buy” rating by UBS on Tuesday, November 19.

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Finance.Yahoo.com which released: “The AbbVie (NYSE:ABBV) Share Price Is Up 44% And Shareholders Are Holding On – Yahoo Finance” on January 11, 2020, also Fool.com with their article: “Why AbbVie Could Be a Great Buy in 2020 – Motley Fool” published on January 13, 2020, Finance.Yahoo.com published: “How Did AbbVie Inc (ABBV) Perform In Comparison to Hedge Fund Favorites in 2019? – Yahoo Finance” on December 29, 2019. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Fool.com and their article: “5 Key Things Investors Should Look Forward to With AbbVie in 2020 – Motley Fool” published on January 16, 2020 as well as Fool.com‘s news article titled: “Is AbbVie’s Stock a Buy? – The Motley Fool” with publication date: January 01, 2020.

Endurant Capital Management Lp decreased Liquidia Technologies Inc stake by 150,988 shares to 317,993 valued at $1.13M in 2019Q3. It also reduced Sanofi (NYSE:SNY) stake by 53,414 shares and now owns 67,200 shares. Encompass Health Corp was reduced too.

Investors sentiment decreased to 1.06 in Q3 2019. Its down 0.10, from 1.16 in 2019Q2. It worsened, as 63 investors sold ABBV shares while 534 reduced holdings. 131 funds opened positions while 504 raised stakes. 979.72 million shares or 3.06% more from 950.66 million shares in 2019Q2 were reported. Professional Advisory Service accumulated 3,000 shares. Fort LP stated it has 0.27% of its portfolio in AbbVie Inc. (NYSE:ABBV). Quantitative Systematic Strategies Ltd Limited Liability Company stated it has 0.05% in AbbVie Inc. (NYSE:ABBV). Hillsdale Inv Mngmt holds 0.05% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 7,590 shares. Beech Hill Advsrs invested in 2.35% or 57,984 shares. Sumitomo Life Insur has 0.54% invested in AbbVie Inc. (NYSE:ABBV). Sector Pension Investment Board holds 0.15% or 287,090 shares in its portfolio. Manufacturers Life Insurance The accumulated 1.88M shares or 0.16% of the stock. Evanson Asset Management Limited Liability Company invested in 0.06% or 3,609 shares. 6,050 were reported by Bessemer Secs Ltd Co. Connors Investor owns 17,890 shares for 0.19% of their portfolio. Premier Asset Management Lc holds 0.63% or 34,920 shares. Stewart And Patten Ltd Limited Liability Company reported 14,604 shares. Lpl Financial Limited Liability invested in 1.02 million shares. Tortoise Investment Limited Liability Company holds 514 shares or 0.01% of its portfolio.

Since July 29, 2019, it had 6 insider purchases, and 0 insider sales for $9.56 million activity. The insider Gosebruch Henry O bought $2.02M. On Monday, September 16 Schumacher Laura J bought $1.76M worth of AbbVie Inc. (NYSE:ABBV) or 25,000 shares. AUSTIN ROXANNE S bought $3.62M worth of AbbVie Inc. (NYSE:ABBV) on Wednesday, July 31. $1.00M worth of stock was bought by Stewart Jeffrey Ryan on Friday, August 16. 7,525 shares valued at $498,057 were bought by Donoghoe Nicholas on Thursday, August 29.

The stock increased 0.74% or GBX 36 during the last trading session, reaching GBX 4881. About 135,990 shares traded. The Berkeley Group Holdings plc (LON:BKG) has 0.00% since January 16, 2019 and is . It has by 0.00% the S&P500.

The Berkeley Group Holdings plc, together with its subsidiaries, engages in the residential-led and mixed-use property development activities in the United Kingdom. The company has market cap of 6.14 billion GBP. The firm manufactures homes, neighbourhoods, communities, luxury homes, and affordable housing for families, first time buyers, students, and senior people in London and the south of England markets. It has a 12.2 P/E ratio. It operates under the Berkeley, St Edward, St George, St James, St Joseph, St William, Berkeley First, Berkeley Commercial, and Berkeley Partnership brands.

More important recent The Berkeley Group Holdings plc (LON:BKG) news were published by: Finance.Yahoo.com which released: “Is The Berkeley Group Holdings plc’s (LON:BKG) CEO Paid At A Competitive Rate? – Yahoo Finance” on January 01, 2020, also Finance.Yahoo.com published article titled: “If You Had Bought Berkeley Group Holdings (LON:BKG) Stock Five Years Ago, You Could Pocket A 77% Gain Today – Yahoo Finance”, Finance.Yahoo.com published: “Why We Like The Berkeley Group Holdings plc’s (LON:BKG) 23% Return On Capital Employed – Yahoo Finance” on August 05, 2019. More interesting news about The Berkeley Group Holdings plc (LON:BKG) was released by: Finance.Yahoo.com and their article: “The Berkeley Group Holdings (LON:BKG) Share Price Has Gained 67% And Shareholders Are Hoping For More – Yahoo Finance” with publication date: May 14, 2019.

AbbVie Inc. (NYSE:ABBV) Ratings Chart